Catalyst Wire Dossier Catalyst Wire Dossier

SPIROMAX (budesonide/formoterol) inhalation powder

budesonide/formoterol · Teva Branded Pharmaceutical Products R&D, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPIROMAX (budesonide/formoterol) inhalation powder, covering 2023-12-08 to 2023-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER® [Phase 3]

See pricing